Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q3 FY20 results · Oct–Dec 2019
Wockhardt reported revenue from operations of ₹869.15 crore (down 16.9% from Q3 FY19) and net profit of ₹19.21 crore for Q3 FY20 (Oct–Dec 2019), on a consolidated basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 869.15 | 1,045.86 | −16.9% | 802.18 | +8.3% |
| Other income | 17.20 | 2.08 | +726.9% | (0.20) | Turned profit |
| Total income | 886.35 | 1,047.94 | −15.4% | 801.98 | +10.5% |
| Profit before tax | 16.42 | (120.59) | Turned profit | (70.55) | Turned profit |
| Net profit for the period | 19.21 | (76.86) | Turned profit | (94.24) | Turned profit |
| Attributable to shareholders of the company | 9.63 | — | — | (82.17) | Turned profit |
| EPS, basic (₹) | 0.87 | (6.42) | Turned profit | (7.42) | Turned profit |
| Net margin (%) | 2.2 | -7.3 | -11.7 |
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 328.74 | 508.60 | −35.4% | 424.28 | −22.5% |
| Other income | 19.77 | 5.90 | +235.1% | 2.01 | +883.6% |
| Total income | 348.51 | 514.50 | −32.3% | 426.29 | −18.2% |
| Profit before tax | (86.86) | (84.40) | Loss widened | 1.48 | Turned loss |
| Net profit for the period | (69.84) | (38.36) | Loss widened | 0.07 | Turned loss |
| EPS, basic (₹) | (6.31) | (3.46) | Loss widened | 0.01 | Turned loss |
| Net margin (%) | -21.2 | -7.5 | 0.0 |
Consolidated
- Filed with BSE
- 27 Jan 2020, 17:38 IST
- Board meeting
- 27 Jan 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 27 Jan 2020, 17:38 IST
- Board meeting
- 27 Jan 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE